© 2026 Improve the News Foundation.
All rights reserved.
Version 7.17.0
Women with the exact same diagnosis keep getting pills while men get the stent, the bypass, the transplant or the deep brain stimulation. No clinical guideline anywhere recommends treating women differently, so these gaps come from assumptions. Kidney disease gets missed because tests built around male muscle mass flag it too late, and men still get transplants far more often.
The numbers don't back up these claims. In the U.S., females made up 58% of participants in NIH-funded trials over nearly three decades, and women's health research draws more government funding than men's. Meanwhile, men die of heart disease at far higher age-adjusted rates, a fact buried by campaigns built on raw death counts. Treatment differences track real differences in risk.